Some Donor Livers Keep Working for 100 Years: Study
TUESDAY, Oct. 18, 2022 (HealthDay News) — Some human livers are tougher than others, lasting more than 100 cumulative years between the organ’s original host and a transplant recipient, a new study discovers.Understanding what makes these livers so r…
Learn MoreMaternal Exposure to PFAS Tied to Reproductive Function of Male Offspring
MONDAY, Oct. 17, 2022 (HealthDay News) — There is a consistent inverse association between maternal exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) and semen quality in young adult male offspring, according to a study published onlin…
Learn MoreYou Can Now Buy Hearing Aids Over-the-Counter. Experts Offer Tips for Consumers
MONDAY, Oct. 17, 2022 (HealthDay News) — It’s official: Older Americans with hearing loss can now stroll into a big box store or pharmacy — or just visit a website — and buy hearing aids without a prescription.The U.S. Food and Drug Administration re…
Learn MoreHistory of Migraine Tied to Poor Sleep in Women
FRIDAY, Oct. 14, 2022 (HealthDay News) — A history of migraine is associated with poor sleep in both premenopausal and perimenopausal women; however, the reasons why may be different depending on menopause status, according to a study presented at th…
Learn MoreOnline Symptom Checkers Often Not Accurate for ID’ing Skin Rashes
TUESDAY, Oct. 18, 2022 (HealthDay News) — Online symptom checkers are often inaccurate in identifying skin rashes, according to a study published online Oct. 12 in the Journal of the American Academy of Dermatology.Nicholas A. Berry, from the Mayo Cl…
Learn MoreKidney Stones Can Be Excruciating. New Treatment Blasts Them Away, No Anesthesia Needed
WEDNESDAY, Oct. 12, 2022 (HealthDay News) — A new ultrasound treatment for kidney stones might provide pain-free relief while the patient is awake, researchers say.Kidney stones are often excruciatingly painful. In most cases, patients are told to ju…
Learn MoreUn medicamento muestra potencial para la esclerodermia, una enfermedad autoinmune
LUNES, 10 de octubre de 2022 (HealthDay News) — Los investigadores informan un éxito temprano con el uso de un medicamento existente para la artritis reumatoide (AR), para tratar la esclerosis sistémica, una afección autoinmune rara pero potencialmen…
Learn MoreLenabasum Studied for Refractory Cutaneous Dermatomyositis
TUESDAY, Oct. 11, 2022 (HealthDay News) — Lenabasum is well tolerated for the treatment of amyopathic dermatomyositis, according to a phase 2 study published online Oct. 1 in the Journal of Investigative Dermatology.Victoria P. Werth, M.D., from the …
Learn MoreDrug Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 (HealthDay News) — Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition. The disease, a subset of scleroderma…
Learn MoreU.S. to Screen Travelers From Uganda for Ebola Amid Outbreak in That Country
FRIDAY, Oct. 7, 2022 (HealthDay News) — Travelers flying from Uganda will be funneled to one of five U.S. airports so they can be screened for Ebola amid an outbreak in that African country, federal officials announced Thursday.Passengers who have be…
Learn More